missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Digoxin Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Supplier: Merck Emd Millipore PHR1771300MG
Description
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Digoxin is one of the digitalis glycosides, extensively utilized for the treatment of congestive heart failure (CHF). It exhibits positive inotropic effects, antiarrhythmic as well as vasoconstrictor actions. It is reported that digoxin and other cardiac glycosides could play important role in the prevention and/or treatment of proliferative diseases like cancer. Featured Industries: Pharmaceutical (small molecule)Specifications
| 20830-75-5 | |
| C41H64O14 | |
| Digoxin; 12 beta-Hydroxydigitoxin | |
| 300 mg | |
| Certified Reference Material |
| These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available. | |
| MFCD00003674 | |
| Certified Reference Material | |
| 780.94 |